Women's Intervention Nutrition Study (WINS): Randomized Study to Determine the Efficacy of Dietary Fat Reduction in Addition to Conventional Systemic Adjuvant Therapy in Postmenopausal Women Surgically Treated for Primary Invasive Breast Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
|Phase III||Treatment||Closed||48 to 78||Other||AHF-WINS|
MRMC-CTCA-9604, WINS-1, NCI-H94-0001, NCT00002564
Dietary fat may be involved in the growth of cancer cells. Restricting dietary fat may help fight cancer.
Randomized clinical trial to study the effectiveness of a low fat diet in treating postmenopausal women who have stage I, stage II, or stage IIIA breast cancer that has been completely removed by surgery.
- 48-78 years old
- Patients must be receiving tamoxifen
- For more information about the eligibility criteria for this trial, refer to the Health Professional version.
Final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Patients will be randomly assigned to one of two groups. During individual and group counseling sessions, patients in group one will receive detailed instructions for following a low fat diet. Patients in group two will receive dietary guidelines with minimal counseling. All patients will receive follow-up evaluations once a year during the study.
For more details about this trial, refer to the Health Professional version of the trial summary.
If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.
Trial Lead Organizations
Institute for Cancer Prevention
|Daniel Nixon, MD, Protocol chair|
|Official Title||A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF A DIETARY FAT REDUCTION PROGRAM PROVIDED IN ADDITION TO SYSTEMIC ADJUVANT THERAPY IN THE MANAGEMENT OF PATIENTS WITH PRIMARY INVASIVE BREAST CANCER|
|Trial Start Date||1994-04-01|
|Registered in ClinicalTrials.gov||NCT00002564|
|Date Submitted to PDQ||1994-04-01|
|Information Last Verified||2010-02-11|
|NCI Grant/Contract Number||CA17613, CA45504|